首页> 外国专利> ANTIMICROBIAL COMBINATION WITH RESPECT TO SUSTAINABLE CARBAPENES OF GRAMORATORAL BACTERIA OF KLEBSIELLA PNEUMONIAE KIND, PRODUCING METAL-β-LACTAMAZ

ANTIMICROBIAL COMBINATION WITH RESPECT TO SUSTAINABLE CARBAPENES OF GRAMORATORAL BACTERIA OF KLEBSIELLA PNEUMONIAE KIND, PRODUCING METAL-β-LACTAMAZ

机译:产生肺炎克雷伯菌肺炎菌种细菌对细菌持久性碳的抗菌结合

摘要

The invention relates to the field of medicine, in particular to clinical microbiology, and can be used to overcome the resistance of Gram-negative bacteria of the species Klebsiella pneumoniae, producing metallo-β-lactamase (ML), to carbapenems. This technical result is achieved by the fact that clodronic or etidronovy acid from the group of bisphosphonates inhibit the standard reagent - metallo-β-lactamase P. aeruginosa, recombinant, expressed in Escherichia coli. The achieved result allowed to reveal the antimicrobial effect of the combination of clodronic or etidronic acids with carbapenems (imipenem or meropenem) in relation to the reference strain K.pneumoniae ATCC 70603, resistant to carbapenems, in the presence of the standard МβЛ reactive inactivating these antibiotics The proposed solution allows to simulate the production of strains of gram-negative microorganisms with different levels of resistance to carbapenems and to assess the effectiveness of inhibition of MβL.
机译:本发明涉及医学领域,尤其涉及临床微生物学,并且可以用于克服产生金属β-内酰胺酶(ML)的肺炎克雷伯菌的革兰氏阴性细菌对碳青霉烯类的抗性。该技术结果是通过以下事实来实现的:双膦酸盐类的氯膦酸或乙二膦酸抑制了在大肠杆菌中表达的标准试剂-重组金属β-内酰胺酶铜绿假单胞菌。所获得的结果允许揭示在标准МβЛ反应性失活的情况下,氯膦酸或依替膦酸与碳青霉烯类(亚胺培南或美罗培南)的组合相对于参考菌株K.pneumoniae ATCC 70603具有抗碳青霉烯类的抗微生物作用。抗生素拟议的解决方案可以模拟对碳青霉烯具有不同水平耐药性的革兰氏阴性微生物菌株的产生,并评估MβL抑制的有效性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号